Sun Pharma signs US deal under MFN pricing to lower drug prices
Sun Pharmaceutical Industries signed a deal with the US government to lower prices of its innovative drugs in the US under the most favoured nation (MFN) pricing framework, aligned with the lowest prices paid by other developed nations.
New Delhi, Sept.
1 -- Drug major Sun Pharmaceutical Industries has signed a deal with the US government to lower prices of its innovative drugs in the US, in line with the lowest prices paid by other developed nations, under the most favoured nation (MFN) pricing framework.
It has also committed to…